PapersFlow Research Brief
Aortic Disease and Treatment Approaches
Research Guide
What is Aortic Disease and Treatment Approaches?
Aortic disease and treatment approaches encompass the diagnosis and management of conditions such as aortic dissection, bicuspid aortic valve disease, thoracic aortic aneurysms, and techniques including endovascular repair.
The field includes 65,596 published works on aortic pathologies and their treatments. Research covers risk prediction, surgical outcomes, complications, and long-term survival rates in patients with aortic diseases. Key focuses are aortic dissection, thoracic aortic aneurysms, and endovascular repair methods.
Topic Hierarchy
Research Sub-Topics
Type B Aortic Dissection Management
This sub-topic evaluates medical, surgical, and endovascular therapies for uncomplicated and complicated Type B aortic dissections. Researchers study false lumen patency and long-term outcomes using IRAD data.
Thoracic Aortic Aneurysm Risk Prediction
This sub-topic develops genetic, biomechanical, and imaging-based models for thoracic aortic aneurysm progression and rupture risk. Researchers integrate guidelines for surveillance and intervention timing.
Bicuspid Aortic Valve Associated Aortopathy
This sub-topic investigates the pathogenesis, dilation patterns, and surgical indications for aortopathy in bicuspid aortic valve disease. Researchers correlate valve morphology with aortic complications.
Endovascular Repair of Aortic Diseases
This sub-topic compares TEVAR and EVAR outcomes, complications like spinal cord ischemia, and durability against open repair. Researchers analyze randomized trials and real-world registries.
Transcatheter Aortic Valve Replacement Outcomes
This sub-topic assesses TAVR efficacy, safety, and long-term survival in high-risk and intermediate-risk patients with aortic stenosis. Researchers compare self-expanding and balloon-expandable prostheses.
Why It Matters
Aortic diseases contribute to high in-hospital mortality, with acute aortic dissection showing persistent high rates despite diagnostic advances, as documented in the International Registry of Acute Aortic Dissection (IRAD) involving over 450 patients across 12 centers (Hagan et al., 2000). Transcatheter aortic-valve replacement (TAVR) offers survival benefits in high-risk patients with severe aortic stenosis, achieving similar 1-year survival to surgical replacement in one trial (Smith et al., 2011) and superior rates with self-expanding prostheses in another (Adams et al., 2014). Endovascular repair proves preferable over open surgery for abdominal aortic aneurysms at least 5 cm in diameter, based on randomized trial results (Prinssen et al., 2004). Guidelines like the 2014 ESC recommendations standardize diagnosis and treatment across thoracic and abdominal aortic diseases (Authors Task Force Members et al., 2014), while pharmacological interventions such as losartan prevent aneurysm formation in Marfan syndrome mouse models by blocking TGF-β signaling (Habashi et al., 2006). These approaches reduce periprocedural risks and improve outcomes in vascular surgery and cardiology.
Reading Guide
Where to Start
"Transcatheter versus Surgical Aortic-Valve Replacement in High-Risk Patients" (Smith et al., 2011) provides an accessible entry via its randomized comparison of survival rates and risks in high-risk aortic stenosis patients, foundational for understanding treatment evolution.
Key Papers Explained
Smith et al. (2011) established similar 1-year survival between transcatheter and surgical aortic-valve replacement in high-risk patients, setting the stage for refinements like the self-expanding prosthesis in Adams et al. (2014), which showed superior survival. Hagan et al. (2000) characterized acute aortic dissection variability and high mortality, informing guidelines in Authors Task Force Members et al. (2014) and Hiratzka et al. (2010). Prinssen et al. (2004) demonstrated endovascular superiority for aneurysms, echoed in ESVS guidelines (Wanhainen et al., 2018). Habashi et al. (2006) linked TGF-β to aneurysms via Marfan models.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Guidelines continue shaping practice, with 2014 ESC (Authors Task Force Members et al., 2014) and 2019 ESVS (Wanhainen et al., 2018) addressing management gaps. No recent preprints or news indicate focus on established high-citation works for thoracic aneurysms, dissections, and valve interventions.
Papers at a Glance
Frequently Asked Questions
What are the survival outcomes of transcatheter versus surgical aortic-valve replacement in high-risk patients?
In high-risk patients with severe aortic stenosis, transcatheter aortic-valve replacement showed similar 1-year survival rates to surgical replacement, though with different periprocedural risks (Smith et al., 2011). A self-expanding prosthesis trial reported significantly higher 1-year survival with TAVR compared to surgery (Adams et al., 2014).
What do guidelines recommend for aortic disease diagnosis and treatment?
The 2014 ESC Guidelines cover diagnosis and treatment of acute and chronic thoracic and abdominal aortic diseases in adults (Authors Task Force Members et al., 2014). The 2010 ACCF/AHA guidelines address thoracic aortic disease management (Hiratzka et al., 2010).
What are key clinical features of acute aortic dissection?
Acute aortic dissection manifests variably, with classic findings often absent, requiring high clinical suspicion (Hagan et al., 2000). In-hospital mortality remains high despite advances, emphasizing needs in prevention and diagnosis.
How does endovascular repair compare to open repair for abdominal aortic aneurysms?
Endovascular repair is preferable to open repair for abdominal aortic aneurysms at least 5 cm in diameter, per randomized trial results (Prinssen et al., 2004). Long-term follow-up assesses sustained advantages.
What prevents aortic aneurysm in Marfan syndrome models?
Losartan, an AT1 antagonist, prevents aortic aneurysm in a Marfan syndrome mouse model by blocking excessive TGF-β signaling (Habashi et al., 2006).
What factors are associated with calcific aortic valve disease?
Clinical factors linked to calcific aortic valve disease include age, hypertension, and other cardiovascular risks, as identified in population studies (Stewart et al., 1997).
Open Research Questions
- ? How can in-hospital mortality from acute aortic dissection be reduced beyond current diagnostic improvements?
- ? What long-term survival differences emerge between transcatheter and surgical aortic-valve replacement beyond 1 year?
- ? Which patient subgroups benefit most from endovascular over open repair of abdominal aortic aneurysms?
- ? How does TGF-β signaling inhibition translate from Marfan mouse models to human aortic aneurysm prevention?
- ? What refinements are needed in risk prediction for thoracic aortic disease progression?
Recent Trends
The field encompasses 65,596 works with no specified 5-year growth rate.
High-citation papers from 1997-2018 dominate, including 6220 citations for Smith et al. and 4317 for Authors Task Force Members et al. (2014).
2011No recent preprints or news coverage available, sustaining reliance on guidelines and trials like Adams et al. with 2835 citations.
2014Research Aortic Disease and Treatment Approaches with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Aortic Disease and Treatment Approaches with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers